Intelligent Bio Solutions Inc.

INBS

US36151G6008

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 14:27:33 2024-05-15 EDT			5-day change	1st Jan Change
2.325 ^USD	-3.53%		-16.61%	-40.56%

05-08	Earnings Flash (INBS) INTELLIGENT BIO SOLUTIONS Reports Q3 Revenue $823,800	MT
05-08	Intelligent Bio Solutions Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	CI

Intelligent Bio Solutions Inc. announced that it has received $10.116165 million in funding

March 11, 2024

On March 12, 2024, Intelligent Bio Solutions Inc. closed the transaction. The company has raised $10,100,683 from 8 investors pursuant to regulation D.

Latest news about Intelligent Bio Solutions Inc.

Earnings Flash (INBS) INTELLIGENT BIO SOLUTIONS Reports Q3 Revenue $823,800	05-08	MT
Intelligent Bio Solutions Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	05-08	CI
Intelligent Bio Solutions Inc. announced that it has received $10.116165 million in funding	03-11	CI
Intelligent Bio Solutions Inc. announced that it expects to receive $10.116165 million in funding	03-07	CI
Top Premarket Decliners	02-12	MT
Top Midday Gainers	02-09	MT
Earnings Flash (INBS) INTELLIGENT BIO SOLUTIONS Reports Q2 Revenue $764,063	02-09	MT
Intelligent Bio Solutions Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	02-09	CI
Sector Update: Health Care Stocks Advance Late Afternoon	02-02	MT
Sector Update: Health Care Stocks Decline Friday Afternoon	02-02	MT
Top Midday Gainers	02-02	MT
Intelligent Bio Solutions Inc. Provides Unaudited Preliminary Earnings Guidance for the Second Quarter and Six Months Ended December 31, 2023	02-02	CI
Sector Update: Health Care Stocks Stronger Late Afternoon	01-29	MT
Sector Update: Health Care	01-29	MT
Intelligent Bio Solutions Says Fingerprinting Drug Screening System Being Used by UK Timber Processor; Shares Soar	01-29	MT
James Jones & Sons Ltd. Adopts Intelligent Bio Solutions Inc.'s Fingerprint Drug Screening System Across its 25 Sites and 1,300 Employees	01-29	CI
Intelligent Bio Solutions Inc. Announces Selection of the Revolutionary Portable Intelligent Fingerprinting Drug Screening System by Dgp plc	01-22	CI
Intelligent Bio Solutions Receives NATA Accreditation for Its Revolutionary Fingerprint Sweat Drug Screening System	12-19	CI
P&O Ferries, Adopts Fingerprint Drug Screening Solution for On-Board, Random Testing of Seafaring Staff	12-05	CI
Intelligent Bio Solutions Inc. Announces Titan Cranes and Rigging Pty Ltd. Adopts Intelligent Fingerprinting Drug Screening System	11-30	CI
Intelligent Bio Solutions to Provide Fingerprinting Drug Screening System to Australian Firm; Shares Rise	11-27	MT
Wall Street Set to Open Slightly Higher as Investors Parse Powell Remarks	11-10	MT
Top Premarket Gainers	11-10	MT
Sector Update: Health Care Stocks Falling Late Afternoon	11-09	MT
Top Midday Gainers	11-09	MT

Chart Intelligent Bio Solutions Inc.

Duration

Period

More charts

Intelligent Bio Solutions Inc. is a life sciences company. The Company is engaged in developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. It operates through two segments, namely Commercially available Intelligent Fingerprinting Products (IFPG) and Development Stage Saliva Glucose Biosensor Platform (SGBP). Its product portfolio includes a portable drug screening system that works by analyzing fingerprint sweat using a one-time cartridge and portable handheld reader and also includes a development stage range of biosensor- based Point of Care diagnostic tests (POCT) that are developed in the modalities of clinical chemistry, immunology, tumor markers, allergens, and endocrinology. Its product candidate is the Saliva Glucose Biosensor (SGB), a POCT expected to substitute the finger pricking invasive blood glucose monitoring for diabetic patients. Its Biosensor Platform helps to detect multiple biological analytes.

Sector

Biotechnology & Medical Research

Calendar

2024-11-05 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Intelligent Bio Solutions Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

2.39 USD

Average target price

42 USD

Spread / Average Target

+1,657.32%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Bio Diagnostics & Testing

	1st Jan change	Capi.
INTELLIGENT BIO SOLUTIONS INC.	-40.56%	6.8M
EXACT SCIENCES CORPORATION	-27.30%	9.96B
GUARDANT HEALTH, INC.	-8.47%	3.03B
IOVANCE BIOTHERAPEUTICS, INC.	+33.64%	3B
BGI GENOMICS CO., LTD.	-14.73%	2.18B
VERACYTE, INC.	-14.29%	1.76B
MARAVAI LIFESCIENCES HOLDINGS, INC.	+64.50%	1.42B
CAREDX, INC	+25.00%	794M
SEEGENE, INC.	-2.18%	756M
CURIOX BIOSYSTEMS CO., LTD	+3.18%	305M

Bio Diagnostics & Testing